Delivery Order SPE2DR25D3201-SPE2DR26FT5MS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15.7K to supply Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The award represents a non-competitive, non-set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. Performance...
- The Defense Logistics Agency awarded a $24,468.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Jemperli 500 mg/10 ml vials. This non-competitive delivery order is scheduled for completion by February 9, 2026, with fulfillment occurring at the awardee's facility in Conshohocken, Pennsylvania. Jemperli is a specialized oncology medication used in the treatment of certain hematologic malignancies, representing the type of critical...
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $94,237.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Jemperli 500 mg/10 mL vials. This non-set-aside contract is scheduled for completion by December 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Jemperli is a specialized oncology medication used in the treatment of certain hematologic malignancies, reflecting the critical role AmerisourceBergen...
- The Defense Logistics Agency awarded a $37,259.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of JEMPERLI 500 mg/10 mL vials. This non-set-aside competitive award was issued on August 1, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. JEMPERLI is a specialized pharmaceutical product, and this order represents one of many...
- The Defense Logistics Agency awarded a $29,807.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jemperli 500 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $113,363.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product JEMPERLI 500 MG/10 ML VIAL 10ML, with a potential value of $6,992.05. The order has a completion date of January 22, 2024 and was awarded on December 28, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $34,009.17 firm fixed-price contract is for the supply of the prescription drug JEMPERLI 500 MG/10 ML VIAL 10ML. There is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,355.67 contract is for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is not set aside and has an ultimate completion date of July 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,312.56 to AmerisourceBergen Drug Corp for 500 mg/10 mL vials of Jemperli, an oncology medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of February 10, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2031 that serves as the primary mechanism for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that regularly fulfills DLA procurement requirements across multiple therapeutic domains. The parent company, Cencora, Inc., maintains significant contract relationships with the Department of Defense and other federal healthcare systems, demonstrating substantial capability to supply specialized medications and medical commodities to military treatment facilities and veterans' healthcare programs. The delivery order for Jemperli reflects the contractor's established role in providing oncology medications and other essential pharmaceutical products through the DLA's flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 1/19/26 |